⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CSTL News
Castle Biosciences, Inc. Common Stock
Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
globenewswire.com
CSTL
Form 8-K
sec.gov
CSTL
Castle Biosciences Reports Fourth Quarter and Full–Year 2025 Results
globenewswire.com
CSTL
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
globenewswire.com
CSTL
Merlin CP-GEP Becomes the First and Only Gene Expression Profile (GEP) Test Recommended by NCCN® Cutaneous Melanoma Guidelines to Assess Metastatic Risk
prnewswire.com
CSTL
Orion Nuclear Energy Corporation and Constellis Announce Strategic Collaboration to Advance Security Standards for Nuclear and Critical Infrastructure
prnewswire.com
CSTL
Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026
globenewswire.com
CSTL
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
globenewswire.com
CSTL
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CSTL
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
globenewswire.com
CSTL